Fosfomycin (Savara)

N/A

Report date: 2025/01/26 18:30:08
NME

Base Information

Drug NameFosfomycin (Savara)
Drug Alias NamefosfomycinFosfomycin (Savara)Fosfomycin (SerendeX)Fosfomycin (SerendeX)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultCystic FibrosisPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerendex Pharmaceuticals AS
China Registration ClassN/A

Develop Information

Active CompaniesSavara Inc
Inactive CompaniesSerendex Pharmaceuticals AS
Active IndicationsRespiratory Distress Syndrome, AdultCystic FibrosisPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A